Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Bartronics India Ltd. Capital/Financing Update 2025

Dec 10, 2025

64057_rns_2025-12-10_d1bf4b31-686c-454c-a000-c58306efad90.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

10[th] December, 2025

To,
BSE Limited,
Listing Department, P.J. Towers, Dalal
Street, Mumbai – 400 001
Scrip Code: 532694
To,
National Stock exchange of India Limited,
Exchange Plaza, C-1, Block G,
Bandra Kurla Complex, Bandra (E)
Mumbai – 400 051
Symbol: ASMS

Dear Sir/Madam,

Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure - - Requirements) Regulations, 2015 Incorporation of Wholly owned Subsidiary

With reference to our earlier intimation dated 23rd September, 2025and pursuant to Regulations 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby wish to inform that the Ministry of Corporate Affairs has approved incorporation of wholly owned subsidiary of the Bartronics India Limited (“the Company”) in the name of “ BIL Healthtech Private Limited ” on December 09, 2025. The Ministry of Corporate Affairs, has issued a Certificate of Incorporation for the same.

In accordance with the requirements Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 Dated July 13, 2023 we hereby provide the requisite disclosures in the attached Annexure A.

You are requested to kindly take the above information on record.

Thanking You,

Yours Faithfully,

For Bartronics India limited

N VIDHYA Digitally signed by N VIDHYA SAGAR SAGAR REDDY Date: 2025.12.10 REDDY 17:17:56 +05'30'

N Vidhya Sagar Reddy Managing Director DIN: 09474749

Annexure A

Details required under Regulation 30 Read with Schedule III of the Securities and Exchange Board of India (“SEBI") (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“LODR”) and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 Dated July 13, 2023.

2023.
Sl.no. Particulars Details
**a) ** Name of the target entity, details in brief
such as size, turnover etc.
Name: BIL Healthtech Private Limited
CIN: U62099TS2025PTC207421
Authorised Share Capital:Rs.10,00,000/-
(Rupees Ten Lakhs only) divided into
1,00,000 equity shares of ₹10/-each.
Paid-up Share Capital:Rs. 1,00,000/-
(Rupees One Lakh only) divided into 10,000
equity shares of ₹10/-each
Turnover:Not Applicable, since it is a
newlyincorporated company..
**b) ** Whether the acquisition would fall within
related party transaction(s) and whether
the promoter/ promoter group/ group
companies have any interest in the entity
being acquired? If yes, nature of interest
and details thereof and whether the same
is done at “arm’s length”;
BIL Healthtech Private Limited is the WOS
of Bartronics India Limited (“BIL”).
Accordingly,
BIL
Healthtech
Private
Limited is a related party.
BIL hold 100% share capital in BIL
Healthtech Private Limited.
**c) ** Industry to which the entity being
acquired belongs
 Health-tech
services
and
related
activities.
 Other
Information
technology
and
services
**d) ** Objects
and
impact
of
acquisition
(including but not limited to, disclosure
of reasons for acquisition of target entity,
if its business is outside the main line of
business of the listed entity);
The incorporation of WOS aligns with the
Company's strategic objective to diversify
and expand the current business operations.
**e) ** Brief details of any governmental or
regulatory approvals required for the
acquisition/incorporation;
Not Applicable
**f) ** Indicative time period for completion of
the acquisition/incorporation
Not Applicable
**g) ** Nature of Consideration - whether cash 100% subscription to the Share Capital will
consideration or share swap or any other be in Cash.
form and details of the same;
**h) ** Cost of acquisition and/or the price at The initial share capital subscribed at the
which the shares are acquired; time of Incorporation to be issued at face
value.
**i) ** Percentage of shareholding / control 100%
acquired and / or number of shares
acquired
**j) ** Brief
background
about
the
entity
BIL Healthtech Private Limited is Wholly
acquired in terms of products/line of Owned Subsidiary of BIL incorporated in
business acquired, date of incorporation, Hyderabad, Telangana, India.
history of last 3 years turnover, country
in which the acquired entity has presence The main objective of the wholly owned
and any other significant information (in subsidiary (WOS) Company is to provide
brief); and operate HealthTech solutions; supply
and support medical devices; collect and
analyse health data with related consulting
services;
and
deal
in
biotechnology
products, pharmaceuticals, research tools,
health
foods,
chemicals,
life-science
equipment and other emerging technologies.
Turnover: Not Applicable, since it is a
newlyincorporated company.